- Record: found
- Abstract: found
- Article: not found
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Sima Jeha
1 ,
Paul S Gaynon ,
Bassem I Razzouk ,
Janet Franklin ,
Richard Kadota ,
Violet Shen ,
Lori Luchtman-Jones ,
Michael Rytting ,
Lisa R Bomgaars ,
Susan Rheingold ,
Kim Ritchey ,
Edythe Albano ,
Robert J Arceci ,
Stewart Goldman ,
Timothy Griffin ,
Arnold Altman ,
Bruce Gordon ,
Laurel Steinherz ,
Steven Weitman ,
Peter Steinherz
Apr 20 2006
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the efficacy and safety of clofarabine, a novel deoxyadenosine analog, in pediatric patients with refractory or relapsed acute lymphoblastic leukemia (ALL).